gDNA segregation analysis confirmed a further six prostate-cancer-affected relatives as carriers; a final cohort for analysis contained fifteen patients (ATM n = 9, CHEK2 n = 2 and HOXB13G84E n = 4). Here, CHEK2 is linked to prostate carcinoma.